PAVmed Inc.
PAVM· Nasdaq
Released Mar 25, 2024, after the close
10-K filed Mar 25, 2024, 85 days after period end · 0001493152-24-011172
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.05M | $112.00K | — | — |
| Net Income | -$14.04M | -$20.46M | -$17.22M |
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR
| -$8.74M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.